Cargando…
Genetically edited hepatic cells expressing the NTCP-S267F variant are resistant to hepatitis B virus infection
The sodium-dependent taurocholate co-transporting polypeptide (NTCP)-S267F variant is known to be associated with a reduced risk of hepatitis B virus (HBV) infection and disease progression. The NTCP-S267F variant displays diminished function in mediating HBV entry, but its function in HBV infection...
Autores principales: | Uchida, Takuro, Park, Seung Bum, Inuzuka, Tadashi, Zhang, Min, Allen, Joselyn N., Chayama, Kazuaki, Liang, T. Jake |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608598/ https://www.ncbi.nlm.nih.gov/pubmed/34853804 http://dx.doi.org/10.1016/j.omtm.2021.11.002 |
Ejemplares similares
-
Effect of S267F variant of NTCP on the patients with chronic hepatitis B
por: Lee, Hye Won, et al.
Publicado: (2017) -
Establishment of a Monoclonal Antibody against Human NTCP That Blocks Hepatitis B Virus Infection
por: Takemori, Toshitada, et al.
Publicado: (2022) -
Diverse Effects of the NTCP p.Ser267Phe Variant on Disease Progression During Chronic HBV Infection and on HBV preS1 Variability
por: Yang, Fangji, et al.
Publicado: (2019) -
The NTCP p.Ser267Phe Variant Is Associated With a Faster Anti-HBV Effect on First-Line Nucleos(t)ide Analog Treatment
por: Wu, Lina, et al.
Publicado: (2021) -
NTCP and Beyond: Opening the Door to Unveil Hepatitis B Virus Entry
por: Watashi, Koichi, et al.
Publicado: (2014)